financetom
Business
financetom
/
Business
/
KKR Rival Bain Capital Reportedly Wins Support of Fuji Soft Founder in Takeover Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
KKR Rival Bain Capital Reportedly Wins Support of Fuji Soft Founder in Takeover Bid
Oct 18, 2024 4:57 AM

07:40 AM EDT, 10/18/2024 (MT Newswires) -- KKR & Co. ( KKR ) rival in the takeover of Fuji Soft, Bain Capital, won support of the Japanese software developer's founder and major shareholder Hiroshi Nozawa, multiple news outlets reported Friday, citing Nozawa's letter to the company.

Bain made a binding offer last week to acquire Fuji Soft for 9,450 yen ($63.03) per share, valuing the company at $4 billion and outbidding KKR by about 7%, according to the reports.

This comes after Fuji Soft said in a Tuesday filing that it was not conducting any discussions with Bain Capital regarding its offer and that its board has recommended shareholders to accept KKR's tender offer of 8,800 yen per share.

In the Thursday letter, Nozawa urged Fuji Soft to withdraw its recommendation to accept KKR's offer as Bain's offer was superior, the media outlets said.

"It is obvious that Bain Capital's purchase price, which is higher than KKR's purchase price, is in the common interest of shareholders," Nozawa said in the letter, according to Reuters.

KKR and Bain Capital did not immediately respond to MT Newswires' request for comment on the matter, while Fuji Soft could not immediately be reached.

Price: 138.00, Change: +0.16, Percent Change: +0.12

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved